ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 256927 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 256927; 2) Community: the network communities that were significantly associated with the response to NSC 256927; 3) Molecule: the relationships between components within communities and NSC 256927; 4) MDR: the compounds that were significantly associated with the NSC 256927.

NSC Compound Enrichment Correlation
NSC 405166 Null 0.0176693828663438 0.21641816
NSC 723565 Null 0.0176693828663438 0.04930745
NSC 726195 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one 0.0176693828663438 0.33129093
NSC 750717 5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one 0.0176693828663438 0.19141244
NSC 363812 Tetraplatin 0.0181211508101517 0.61809543
NSC 371488 9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride 0.0181211508101517 0.099920281
NSC 380721 Eremantholide B 0.0181211508101517 0.44299011
NSC 626715 10-EdAM 0.0181211508101517 0.37853016
NSC 645351 [Bis(aminomethyl)diethylsilane]dichloroplatinum (II) 0.0181211508101517 0.6176925
NSC 680781 2(3H)-Furanone, dihydro-3-[1-[(4-chlorophenyl)amino] ethylidene]- 0.0181211508101517 0.27105052
Total:80  Current:25    [First] [Prev] [Next] [Last]